(Q47697045)

4 February 2018

title

Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome (English)

1 reference

4 February 2018

author name string

Netea MG

series ordinal

1

1 reference

4 February 2018

Kullberg BJ

series ordinal

2

1 reference

4 February 2018

van der Meer JW

series ordinal

3

1 reference

4 February 2018

publication date

1 November 2005

1 reference

4 February 2018

European Journal of Clinical Investigation

published in

1 reference

4 February 2018

volume

35

1 reference

4 February 2018

issue

11

1 reference

4 February 2018

page(s)

718-721

1 reference

4 February 2018

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01564.X

Selective insufficiency of IFN‐γ secretion in patients with hyper‐IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01564.X

Cytokine and chemokine dysregulation in hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01564.X

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01564.X

Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01564.X

10.1111/J.1365-2362.2005.01564.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018